Copyright © 2005 Elsevier Inc. All rights reserved.
Influence of membrane fluidity on human immunodeficiency virus type 1 entry
Received 19 January 2005.
References and further reading may be available for this article. To view references and further reading you must purchase this article.
Abstract
For penetration of human immunodeficiency virus type 1 (HIV-1), formation of fusion-pores might be required for accumulating critical numbers of fusion-activated gp41, followed by multiple-site binding of gp120 with receptors, with the help of fluidization of the plasma membrane and viral envelope. Correlation between HIV-1 infectivity and fluidity was observed by treatment of fluidity-modulators, indicating that infectivity was dependent on fluidity. A 5% decrease in fluidity suppressed the HIV-1 infectivity by 56%. Contrarily, a 5% increase in fluidity augmented the infectivity by 2.4-fold. An increased temperature of 40 °C or treatment of 0.2% xylocaine after viral adsorption at room temperature enhanced the infectivity by 2.6- and 1.5-fold, respectively. These were inhibited by anti-CXCR4 peptide, implying that multiple-site binding was accelerated at 40 °C or by xylocaine. Thus, fluidity of both the plasma membrane and viral envelope was required to form the fusion-pore and to complete the entry of HIV-1.
Keywords: HIV-1; Membrane fluidity; Receptor; Fusion; Multiple-site binding; Viral penetration






E-mail Article
Add to my Quick Links

Cited By in Scopus (6)






and 2A
were measured as shown by arrows. Asterisks show spectra of free 5-DSA remaining in each sample. Order parameters (S-values) of B, C, D, E, F, and G were calculated at 0.611, 0.729, 0.776, 0.585, 0.704, and 0.721, respectively. Scale of the horizontal axis (magnetic field) is shown as 10 G (gauss).